A Multiplex PCR/LDR Assay for the Simultaneous Identification of Category A Infectious Pathogens: Agents of Viral Hemorrhagic Fever and Variola Virus-Reference-Cited by-同舟云学术

A Multiplex PCR/LDR Assay for the Simultaneous Identification of Category A Infectious Pathogens: Agents of Viral Hemorrhagic Fever and Variola Virus

Published:2015-09-18 Issue:9 Volume:10 Page:e0138484
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Das Sanchita,Rundell Mark S.,Mirza Aashiq H.,Pingle Maneesh R.,Shigyo Kristi,Garrison Aura R.,Paragas Jason,Smith Scott K.,Olson Victoria A.,Larone Davise H.,Spitzer Eric D.,Barany Francis,Golightly Linnie M.

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference58 articles.

1. Hemorrhagic fever viruses as biological weapons: medical and public health management;L Borio;JAMA,2002

2. Viral haemorrhagic fevers imported into non-endemic countries: risk assessment and management;B Bannister;Br Med Bull,2010

3. Crimean-Congo hemorrhagic fever virus as a nosocomial pathogen in Iran;M Mardani;Am J Trop Med Hyg,2009

4. Crimean-Congo hemorrhagic fever in Europe: current situation calls for preparedness;HC Maltezou;Euro Surveill

5. Origin of the dengue virus outbreak in Martin County, Florida, USA 2013;FD Teets;Virology Reports,2014

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent Advances in Crimean-Congo Hemorrhagic Fever Virus Detection, Treatment, and Vaccination: Overview of Current Status and Challenges;Biological Procedures Online;2024-06-26

2. Advances in Nucleic Acid Assays for Infectious Disease: The Role of Microfluidic Technology;Molecules;2024-05-21

3. Hemorrhagic fever viruses: Pathogenesis, therapeutics, and emerging and re-emerging potential;Frontiers in Microbiology;2022-10-25

4. Diagnostic Testing for Crimean-Congo Hemorrhagic Fever;Journal of Clinical Microbiology;2020-03-25

5. Prioritising pathogens for the management of severe febrile patients to improve clinical care in low- and middle-income countries;BMC Infectious Diseases;2020-02-10